Torsades de pointes with Almokalant, a new class III antiarrhythmic drug
- 31 October 1993
- journal article
- case report
- Published by Elsevier in American Heart Journal
- Vol. 126 (4) , 1008-1011
- https://doi.org/10.1016/0002-8703(93)90726-p
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Electropharmacologic effects and pharmacokinetics of almokalant, a new class III antiarrhythmic, in patients with healed or healing myocardial infarcts and complex ventricular arrhythmiasThe American Journal of Cardiology, 1992
- Prolonged Action Potential Duration and Positive Inotropy Induced by the Novel Class III Antiarrhythmic Agent H 234/09 (Almokalant) in Isolated Human Ventricular MuscleJournal of Cardiovascular Pharmacology, 1991
- QTU-Prolongation and Torsades de Pointes Induced by Putative Class III Antiarrhythmic Agents in the RabbitJournal of Cardiovascular Pharmacology, 1990
- Paradoxical effects of exercise on the QT interval in patients with polymorphic ventricular tachycardia receiving type Ia antiarrhythmic agents.Circulation, 1990
- The long QT syndromes: A critical review, new clinical observations and a unifying hypothesisProgress in Cardiovascular Diseases, 1988
- Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient careAmerican Heart Journal, 1986